Pulmonary hypertension (PH) is a complex and progressive disease characterized by high blood pressure in the pulmonary arteries. The condition can lead to right heart failure if not promptly diagnosed and treated. This guide aims to provide healthcare professionals with a comprehensive understanding of PH, its pathophysiology, diagnosis, and treatment options.
PH occurs due to increased pulmonary vascular resistance leading to excessive strain on the right ventricle. It can be idiopathic or associated with a range of conditions such as connective tissue disease, left heart disease, or chronic lung disease. The disease process involves vasoconstriction, vascular remodeling, and thrombosis in situ.
Diagnosis of PH can be challenging due to its nonspecific symptoms. However, a high index of suspicion should be maintained in patients with unexplained dyspnea. Diagnostic tools include echocardiography, right heart catheterization, and lung function tests. These tests help to confirm the diagnosis, determine the severity, and identify the cause of PH.
PH treatment aims to control symptoms, slow disease progression, and improve quality of life. Therapeutic options are based on the underlying cause and the severity of PH. General measures include lifestyle modifications, diuretics, and oxygen therapy. Specific therapies may involve endothelin receptor antagonists, phosphodiesterase type 5 inhibitors, or prostacyclin analogs. In severe cases, lung transplantation may be considered.
PH is a severe and progressive disease that requires a comprehensive and multidisciplinary approach for effective management. Early diagnosis and appropriate treatment are critical to improve patient outcomes. As healthcare professionals, it is vital to maintain a high level of suspicion and be aware of the latest diagnostic tools and treatment options to provide the best care for patients with PH.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation